![Thomas Edward Gibbs](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Thomas Edward Gibbs
Corporate Officer/Principal bei H. LUNDBECK A/S
Aktive Beziehungen
Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
---|---|---|---|---|
Lars Søren Rasmussen | M | 65 | 11 Jahre | |
Jeremy Levin | M | 70 | 7 Jahre | |
Santiago Arroyo | M | 64 | 3 Jahre | |
Lars Bang | M | 62 | 36 Jahre | |
Jeffrey Berkowitz | M | 58 | 6 Jahre | |
Gregory M. Bokar | M | 62 |
Sunovion Pharmaceuticals Europe Ltd.
![]() Sunovion Pharmaceuticals Europe Ltd. Pharmaceuticals: MajorHealth Technology Sunovion Pharmaceuticals Europe Ltd. is a British European pharmaceutical company founded in 2013 that is dedicated to improving the lives of patients through the supply of essential medicines. The company is based in London, UK. The company commercializes and distributes a portfolio of specialty brands and hospital products in 40 countries worldwide, both directly and through strategic partnerships. The company's vision is to become a recognized partner of choice through their commercial excellence, patient focus, and presence across the globe. Sunovion Pharmaceuticals Europe aims to have a positive impact on society through their pioneering focus on their environment, social, and governance (ESG) goals. | - |
Lene Skole-Sørensen | F | 65 | 9 Jahre | |
Dorothea Wenzel | M | 55 | 3 Jahre | |
Lars Erik Holmqvist | M | 64 | 9 Jahre | |
Charl van Zyl | M | 57 | 1 Jahre | |
Keld Flintholm Jørgensen | M | 53 | 5 Jahre | |
Dorte Clausen | F | 40 | 2 Jahre | |
Hossein Armandi | M | 62 | 2 Jahre | |
Camilla Andersson | F | 52 | 2 Jahre | |
Thomas Mikkel Mortensen | M | - | - | |
Tarek Samad | M | - | 3 Jahre | |
Palle Holm Olesen | M | - | - | |
Johan Luthman | M | 65 | 5 Jahre | |
Jörg Hornstein | M | 47 | 2 Jahre | |
Stephen L. Freeman | M | 56 |
Sunovion Pharmaceuticals Europe Ltd.
![]() Sunovion Pharmaceuticals Europe Ltd. Pharmaceuticals: MajorHealth Technology Sunovion Pharmaceuticals Europe Ltd. is a British European pharmaceutical company founded in 2013 that is dedicated to improving the lives of patients through the supply of essential medicines. The company is based in London, UK. The company commercializes and distributes a portfolio of specialty brands and hospital products in 40 countries worldwide, both directly and through strategic partnerships. The company's vision is to become a recognized partner of choice through their commercial excellence, patient focus, and presence across the globe. Sunovion Pharmaceuticals Europe aims to have a positive impact on society through their pioneering focus on their environment, social, and governance (ESG) goals. | - |
Antony Loebel | M | 64 |
Sunovion Pharmaceuticals Europe Ltd.
![]() Sunovion Pharmaceuticals Europe Ltd. Pharmaceuticals: MajorHealth Technology Sunovion Pharmaceuticals Europe Ltd. is a British European pharmaceutical company founded in 2013 that is dedicated to improving the lives of patients through the supply of essential medicines. The company is based in London, UK. The company commercializes and distributes a portfolio of specialty brands and hospital products in 40 countries worldwide, both directly and through strategic partnerships. The company's vision is to become a recognized partner of choice through their commercial excellence, patient focus, and presence across the globe. Sunovion Pharmaceuticals Europe aims to have a positive impact on society through their pioneering focus on their environment, social, and governance (ESG) goals. | - |
Juliane Lenzner | F | - | - | |
Jakob Riis | M | 58 | 1 Jahre | |
Lasse Skibsbye | M | 41 | 2 Jahre |
Beziehungs-Chart
Beziehungen zu mehreren Unternehmen
Ehemalige Beziehungen
Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
---|---|---|---|---|
Deborah Dunsire | M | 61 | 5 Jahre | |
Jacob Tolstrup | M | 52 | 25 Jahre | |
Elise Hauge | F | 57 | 4 Jahre |
Statistik
Land | Beziehungen | % des Gesamten |
---|---|---|
Dänemark | 24 | 88,89% |
Vereinigtes Königreich | 3 | 11,11% |
Alter der Beziehungen
Aktive
Vergangene
Herr
Frau
Aufsichtsräte
Führungskräfte
Ursprung der Beziehungen
- Börse
- Insiders
- Thomas Edward Gibbs
- Persönliches Netzwerk